Brandinium

Trademark search for:

ECOGIENE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2005-04-21 — Application filed
  • 2005-05-02 — Application filed
  • 2005-11-18 — Assigned to examiner
  • 2005-11-23 — Examiners amendment -written
  • 2005-11-23 — Examiners amendment e-mailed
  • 2005-11-28 — Examiner's amendment entered
  • 2005-11-30 — Approved for pub - principal register
  • 2005-12-02 — Assigned to lie
  • 2005-12-13 — Law office publication review completed
  • 2006-01-04 — Notice of publication
  • 2006-01-24 — Published for opposition
  • 2006-02-14 — Extension of time to oppose received
  • 2006-05-23 — Attorney/dom.rep.revoked and/or appointed
  • 2006-05-23 — Teas revoke/app/change addr of atty/dom rep received
  • 2006-06-09 — Extension of time to oppose process - terminated
  • 2006-07-25 — Noa mailed - sou required from applicant
  • 2006-11-20 — Assigned to examiner
  • 2007-01-25 — Sou teas extension received
  • 2007-01-25 — Sou extension 1 filed
  • 2007-03-30 — Sou extension 1 granted
  • 2007-07-26 — Final status recorded
  • 2007-12-07 — Application abandoned
  • 2007-12-24 — Application abandoned

Owner Information

BioNeutral Laboratories Corporation USA
Morristown , NJ
BioNeutral Laboratories Corporation USA
Morristown , NJ

Correspondent

JULES E GOLDBERG REED SMITH LLP
599 LEXINGTON AVE 29TH FL
NEW YORK, NY 10022
UNITED STATES

Filing Details

Filing Date:
2005-04-21
Status Date:
2007-07-26
Category:
Pharmaceuticals
Filing Year:
2005

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.